EQT Future and ATHOS, alongside other co-investors, invest in SHL Medical, a world-leading provider of advanced drug delivery solutions
· SHL Medical is a pioneer in medical autoinjectors, which allow patients to safely self-administer medications at home while reducing the burden on healthcare systems · EQT first partnered with SHL Medical in January 2020 through its EQT VIII fund. Having outperformed its business plan since, SHL Medical formulated an ambitious growth strategy until 2030, for which EQT Future, ATHOS and other co-investors will serve as partners · The consortium will support SHL Medical in its next phase of growth, expanding its production footprint to the United States and Europe, while further